Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: Clinicopathological features, efficacy, and factors affecting survival için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: Clinicopathological features, efficacy, and factors affecting survival | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Eylül 2025 | 0 |
| Ekim 2025 | 0 |
| Kasım 2025 | 0 |
| Aralık 2025 | 0 |
| Ocak 2026 | 0 |
| Şubat 2026 | 0 |
| Mart 2026 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| 0534.pdf | 7 |
